fbpx

Role of FDA approved Hyperbaric Oxygen Therapy for managing Diabetic Foot Ulcers, shares HBOT-India

HBOT-India, a leading hyperbaric medicine facility, is sharing the role of FDA-approved Hyperbaric Oxygen Therapy (HBOT) in managing diabetic foot ulcers. The organisation aims to educate people about the benefits of HBOT and its potential in treating diabetic foot ulcers.

Role of FDA approved Hyperbaric Oxygen Therapy for managing Diabetic Foot Ulcers, shares HBOT-India

Gurgaon (Haryana) [India], March 3 (ANI/BusinessWire India): HBOT-India, a leading hyperbaric medicine facility, is sharing the role of FDA-approved Hyperbaric Oxygen Therapy (HBOT) in managing diabetic foot ulcers.

HBOT-India launches one of the First Medical Grade Hyperbaric Oxygen Therapy in Gurugram, Delhi NCR, India

In 2020, according to the International Diabetes Federation (IDF), 463 million people have diabetes in the world, 88 million people in the South Asia region, of this 88 million people, 77 million belong to India.

Hyperbaric oxygen therapy enhances the recovery from brain stroke significantly suggests doctors at HBOT-India

Oxygen therapy, essentially working as 'brain food', provides extra oxygen to the brain which speeds up the process of neuroplasticity' and thus recovery from stroke. Hyperbaric oxygen therapy/Hyperbaric medicine (HBOT) can play a significant role in the management of stroke. HBOT involves breathing oxygen in a suite/chamber pressurized to above atmospheric levels (about 17 times higher than normal).